# TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)

> **NCT07684313** · — · NOT_YET_RECRUITING · sponsor: **Edwards Lifesciences** · enrollment: 75 (estimated)

## Conditions studied

- Heart Valve Diseases
- Heart Diseases
- Cardiovascular Diseases
- Tricuspid Valve Disease

## Interventions

- **DEVICE:** Edwards TRIFORMIS RESILIA heart valve

## Key facts

- **NCT ID:** NCT07684313
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2030-08
- **Final completion:** 2034-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07684313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07684313, "TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07684313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*